SOURCE: Antisoma plc

April 04, 2007 07:01 ET

Antisoma to present at CIBC Biotechnology Conference

LONDON, UK -- (MARKET WIRE) -- April 4, 2007 --

4 April 2007, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference in New York on Wednesday 11 April.

The presentation will take place at 4.15pm EST. A live webcast can be viewed on Antisoma's website and will be available thereafter at

For the live webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.


Daniel Elger                          +44 (0)7909 915068
Director of Communications
Antisoma plc

Background on Antisoma

Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit for further information.

Copyright © Hugin ASA 2007. All rights reserved.

Contact Information